| Literature DB >> 34770978 |
Eka Sunarwidhi Prasedya1, Nur Ardiana1, Hasriaton Padmi1, Bq Tri Khairina Ilhami1, Ni Wayan Riyani Martyasari1, Anggit Listyacahyani Sunarwidhi2, Aluh Nikmatullah3, Sri Widyastuti4, Haji Sunarpi1, Andri Frediansyah5,6,7.
Abstract
The red macroalga Gelidium latifolium is widely distributed in the coastal areas of Indonesia. However, current knowledge on its potential biological activities is still limited. In this study, we investigated the potential bioactive compounds in Gelidium latifolium ethanol extract (GLE), and its cytotoxic effects against the murine B16-F10 melanoma cell line. GLE shows high total phenolic content (107.06 ± 17.42 mg GAE/g) and total flavonoid content (151.77 ± 3.45 mg QE/g), which potentially contribute to its potential antioxidant activity (DPPH = 650.42 ± 2.01 µg/mL; ABTS = 557.01 ± 1.94 µg/mL). ESI-HR-TOF-MS analysis revealed large absorption in the [M-H]- of 327.2339 m/z, corresponding to the monoisotopic molecular mass of brassicolene. The presence of this compound potentially contributes to GLE's cytotoxic activity (IC50 = 84.29 ± 1.93 µg/mL). Furthermore, GLE significantly increased the number of apoptotic cells (66.83 ± 3.06%) compared to controls (18.83 ± 3.76%). Apoptosis was also confirmed by changes in the expression levels of apoptosis-related genes (i.e., p53, Bax, Bak, and Bcl2). Downregulated expression of Bcl2 indicates an intrinsic apoptotic pathway. Current results suggest that components of Gelidium latifolium should be further investigated as possible sources of novel antitumor drugs.Entities:
Keywords: B16-F10; Gelidium latifolium; brassicolene; cytotoxicity; macroalgae
Mesh:
Substances:
Year: 2021 PMID: 34770978 PMCID: PMC8587204 DOI: 10.3390/molecules26216568
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(A) Morphological features of the red seaweed Gelidium latifolium. (B) Total phenolic content (TPC) and total flavonoid content (TFC) of GLE. (C) DPPH radical scavenging activity of GLE. (D) ABTS radical scavenging activity of GLE. Data represented are the mean ± SEM of 3 independent experiments; * indicates significant differences between groups (p < 0.05).
Figure 2ESI-HR-TOF-MS analysis of putative brassicolene in GLE: (A) Extracted ion chromatogram and chemical structure of brassicolene (a m/z of 327.2339 [M-H]-). (B) Negative mode MS1 of brassicolene. (C) Negative mode MS2 of brassicolene. (D) UV absorption in mass spectrometric analysis of brassicolene.
Figure 3Cytotoxic effects of GLE in B16-F10 cells treated for 72 h: (A) The dose–response curve of GLE and doxorubicin (1–1000 µg/mL) cytotoxic activity in B16-F10 melanoma cells. (B) Morphological observation of B16-F10 melanoma cancer cells treated with GLE or doxorubicin for 72 h, scale = 50 µm. (C) Viability staining with calcein-AM (green) and PI (red) in B16-F10 murine melanoma cells treated with GLE or doxorubicin for 72 h. (D) The percentage of PI-stained cells represent dead cells. Different letters denote significant differences between treatments. Scale = 100 µm.
Figure 4Apoptosis-inducing effects of GLE in B16-F10 melanoma cells: (A) Staining with Hoechst33342 reveals chromatin condensation in apoptotic cells; arrowheads = apoptotic nuclei. (B) Corrected total cell fluorescence (CTCF) values of B16-F10 cells treated with GLE and doxorubicin at IC50 concentrations. (C) Calculation of apoptotic nuclei percentage in B16-F10 cells treated with IC50 concentrations of GLE and doxorubicin. (D) Fragmentation of B16-F10 genomic DNA treated with GLE; a 1 kb DNA ladder (250–10,000 bp) was used as a standard; M: DNA 1 kb marker; A: control; B: GLE IC50 concentration; C: doxorubicin IC50 concentration. * Indicates significant difference compared to control (p < 0.05); ** indicates highly significant difference compared to control (p < 0.01). Arrowheads = apoptotic nuclei. White arrows indicate genomic DNA. White dotted arrows show fragmented DNA. Scale = 25 µm.
Figure 5(A) Amplification of the apoptosis-related genes p53, Bax, Bak, and Bcl2. (B) Analyses of gene expression based on mRNA expression relative to the housekeeping gene GAPDH. ** indicates highly significant difference compared to control (p < 0.01).